Mankind Pharma Ltd Share Price – NSE  /  BSE

Pharmaceuticals, Mid Cap

Net profit of Mankind Pharma rose 65.09% to Rs 471.24 crore in the quarter ended March 2024 as against Rs 285.44 crore during the previous quarter ended March 2023. Sales rose 18.92% to Rs 2441.10 crore in the quarter ended March 2024 as against Rs 2052.67 crore during the previous quarter ended March 2023.

For the full year,net profit rose 49.23% to Rs 1912.90 crore in the year ended March 2024 as against Rs 1281.86 crore during the previous year ended March 2023. Sales rose 18.12% to Rs 10334.77 crore in the year ended March 2024 as against Rs 8749.43 crore during the previous year ended March 2023.

Powered by Capital Market - Live News

Mankind Pharma has allotted 46,698 equity shares under ESOP on 10 May 2024. With this allotment, the paid up equity share capital has increased to 40,06,35,138 equity shares having face value of Re. 1/- each.

Powered by Capital Market - Live News

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 15 May 2024

Powered by Capital Market - Live News

Mankind Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 2202.2, down 3.7% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.81% on the day, quoting at 22260.05. The Sensex is at 73429.98, down 0.63%.Mankind Pharma Ltd has eased around 6.63% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has eased around 2.56% in last one month and is currently quoting at 19203.3, down 2.48% on the day. The volume in the stock stood at 1.9 lakh shares today, compared to the daily average of 3.66 lakh shares in last one month.

The PE of the stock is 55.43 based on TTM earnings ending December 23.

Powered by Capital Market - Live News